- Sertraline treatment does not increase plasma prolactin levels in healthy subjects. Gordon, C.; Whale, R.; Cowen, P. J. // Psychopharmacology;1998, Vol. 137 Issue 2, p201
Examines the effect of treatment with another selective serotonin re-uptake inhibitor, sertraline, on plasma prolactin levels in healthy men and women. Mean plasma prolactin concentrations in healthy volunteers; Reasons for the adjustment on the timing of the treatment; Explanation for the...
- Sertraline: A Review of its Use in the Management of Major Depressive Disorder in Elderly Patients. Muijsers, R.B.R.; Plosker, G.L.; Noble, S. // Drugs & Aging;2002, Vol. 19 Issue 5, p377
Sertraline is a selective serotonin reuptake inhibitor (SSRI) with well established antidepressant and anxiolytic activity. Results from several well designed trials show that sertraline (50 to 200 mg/day) is effective in the treatment of major depressive disorder in elderly patients (â‰¥60...
- SSRIs increase risk of postprocedural bleeding. // Reactions Weekly;6/5/2010, Issue 1304, p5
The article discusses a research study on the association between use of selective serotonin reuptake inhibitors (SSRI), specifically sertraline, and increased risk of postprocedural bleeding, published in the May 2010 issue of the journal "Digestive Disease Week."
- These Two Psych Drugs Should Not Be Taken Together. // RN;Apr2003, Vol. 66 Issue 4, p96
Reports that an additional contraindication has been added to the labeling for sertraline HCl, one of the most widely used selective serotonin reuptake inhibitors.
- Sertraline-related Bleeding Tendency: Could it be Dose-dependent? Shahrbabki, Mahin Eslami; Shahrbabaki, Amir Eslami // Iranian Journal of Psychiatry & Behavioral Sciences;Autumn2014, Vol. 8 Issue 3, p81
Selective serotonin reuptake inhibitors (SSRIs) are reported to be associated with increased bleeding tendency. While findings of recent studies explain a lot about the pathophysiology of this side-effect, there is a general tendency to discontinue SSRIs as harmful medications. We report two...
- Adverse effects of SSRIs taken during pregnancy. Thomas, Jack // Australian Journal of Pharmacy;Mar2010, Vol. 91 Issue 1078, p75
The article reports on the study that investigates the effect of intrauterine selective serotonin reuptake inhibitor (SSRI) exposure on pregnancy, which reveals that utero-exposed newborns had increased risk of admission to the neonatal intensive care unit.
- Teratogenic risk of SSRIs used during pregnancy. Huffman, Grace Brooke // American Family Physician;7/1/1998, Vol. 58 Issue 1, p243
Presents a summary of the article `Pregnancy Outcome Following Maternal Use of the New Selective Serotonin Reuptake Inhibitors,' by N.A. Kulin and others, which was published in the February 25, 1998, issue of the `Journal of the American Medical Association.' Examination of the pregnancy...
- SSRI use during pregnancy proliferating. // PharmacoEconomics & Outcomes News;5/31/2008, Issue 554, p9
The article reports on the increase in use of selective serotonin reuptake inhibitors (SSRIs) in pregnancy between 1995 and 2004, according to a population-based cohort study from the Netherlands.
- Treatment with SSRIs during pregnancy increased risk for preterm birth. Thomas, Jack // Australian Journal of Pharmacy;Aug2012, Vol. 93 Issue 1107, p88
The article presents information on the risk of Selective serotonin reuptake inhibitors (SSRIs) treatment during pregnancy.